Detalles de la búsqueda
1.
Cardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert network.
World J Urol
; 42(1): 156, 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483562
2.
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(10): 1094-1108, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37714168
3.
Fully Automated Continuous Centrifugal Microfluidics Isolates Natural Killer Cells with High Performance and Minimal Stress.
Anal Chem
; 95(26): 9949-9958, 2023 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279022
4.
Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.
J Urol
; 209(1): 131-139, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36250938
5.
Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(3): 393-405, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35157830
6.
Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis.
Jpn J Clin Oncol
; 52(5): 441-448, 2022 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35229141
7.
The effect of subsequent immunosuppressant use in organ-transplanted patients on prostate cancer incidence: a retrospective analysis using the Korean National Health Insurance Database.
BMC Urol
; 21(1): 112, 2021 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34419041
8.
Association between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer.
J Urol
; 203(6): 1128-1134, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31845840
9.
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis.
BMC Cancer
; 19(1): 688, 2019 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31307432
10.
Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.
BMC Cancer
; 18(1): 617, 2018 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29855390
11.
The neutrophil-to-lymphocyte ratio makes the Heng risk model improve better the prediction of overall survival in metastatic renal cell cancer patients.
Jpn J Clin Oncol
; 48(9): 835-840, 2018 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30053128
12.
The effect of predisposing atheroembolic risk factors on renal functional recovery between laparoscopy and open technique in patients with T1-stage renal cell carcinoma who underwent partial nephrectomy: a retrospective comparison study.
Jpn J Clin Oncol
; 47(9): 876-882, 2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28637282
13.
Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review.
J Korean Med Sci
; 32(2): 377-381, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28049253
14.
Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy.
Histopathology
; 68(5): 673-9, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26272590
15.
A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy.
BMC Cancer
; 16: 577, 2016 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27484254
16.
Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
World J Surg Oncol
; 14(1): 270, 2016 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27765044
17.
The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer.
BMC Urol
; 15: 82, 2015 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26269129
18.
DHCR24 is an independent predictor of progression in patients with non-muscle-invasive urothelial carcinoma, and its functional role is involved in the aggressive properties of urothelial carcinoma cells.
Ann Surg Oncol
; 21 Suppl 4: S538-45, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24562935
19.
Pelvic floor musculature and bladder neck changes before and after continence recovery after radical prostatectomy in pelvic MRI.
J Magn Reson Imaging
; 39(6): 1431-5, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24023035
20.
Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy.
Can J Urol
; 21(3): 7290-7, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24978359